Mechanism of ganciclovir uptake by rabbit retina and human retinal pigmented epithelium cell line ARPE-19

Current Eye Research

Volumn 29, Issue 2-3, 2004, Pages 127-136

  Majumdar, Soumyajit ^a   Macha, Sreeraj ^a,b   Pal, Dhananjay ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

ARPE 19; Ganciclovir; Nucleobase; Nucleoside; RPE; Transporters

Indexed keywords

ADENINE; ADENOSINE; GANCICLOVIR; INOSINE; NITROBENZYLTHIOINOSINE; NUCLEIC ACID BASE; NUCLEOSIDE; SODIUM; THYMIDINE; TRITIUM;

ANIMAL CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; NONHUMAN; PH; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RABBIT; RETINA; TEMPERATURE DEPENDENCE;

ADENINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; ENERGY METABOLISM; GANCICLOVIR; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; NUCLEOSIDES; PIGMENT EPITHELIUM OF EYE; PURINES; PYRIMIDINES; RABBITS; RETINA; SODIUM; THIOINOSINE; THYMIDINE;

EID: 9344252311     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490504678     Document Type: Conference Paper

References (50)

1. Freeman WR, Lerner CW, Mines JA, Lash RS, Nadel AJ, Starr MB, Tapper ML. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol. 1984;97:133-142.
2. Burd EM, Pulido JS, Puro DG, O'Brien WJ. Replication of human cytomegalovirus in human retinal glial cells. Invest Ophthalmol Vis Sci. 1996;37:1957-1966.
3. Bodaghi B, Michelson S. Cytomegalovirus: Virological facts for clinicians. Ocul Immunol Inflamm. 1999;7:133-137.
4. Andrei G, Snoeck R, Schols D, Goubau P, Desmyter J, De Clercq E. Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus. Eur J Clin Microbiol Infect Dis. 1991;10: 1026-1033.
5. Shigeta S, Konno K, Baba M, Yokota T, De Clercq E. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro. J Infect Dis. 1991;163:270-275.
6. Mar EC, Chiou JF, Cheng YC, Huang ES. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2- propoxymethyl)guanine. J Virol. 1985;53:776-780.
7. Arevalo JF, Gonzalez C, Capparelli EV, Kirsch LS, Garcia RF, Quiceno JI, Connor JD, Gambertoglio J, Bergeron-Lynn G, Freeman WR. Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis. 1995;172:951-956.
8. Kuppermann BD, Quiceno JI, Flores-Aguilar M, Connor JD, Capparelli EV, Sherwood CH, Freeman WR. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: Implications for therapy. J Infect Dis. 1993;168:1506-1509.
9. Cunha-Vaz JG. The blood-retinal barriers. Doc Ophthalmol. 1976;41:287-327.
10. Cadman J. Improved ganciclovir regimens. GMHC Treat Issues. 1997;12:28-29.
11. Cadman J. Ganciclovir implants: One year later. GMHC Treat Issues. 1997;11:3-6.
12. Vazquez E. Saving sight. Posit Aware. 1997;8:22-23.
13. Ashton P, Brown JD, Pearson PA, Blandford DL, Smith TJ, Anand R, Nightingale SD, Sanborn GE. Intravitreal ganciclovir pharmacokinetics in rabbits and man. J Ocul Pharmacol. 1992;8:343-347.
14. Hughes PM, Krishnamoorthy R, Mitra AK. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: A novel ocular microdialysis technique. J Ocul Pharmacol Ther. 1996;12:209-224.
15. Lopez-Cortes LF, Pastor-Ramos MT, Ruiz-Valderas R, Cordero E, Uceda-Montanes A, Claro-Cala CM, Lucero-Munoz MJ. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits. Invest Ophthalmol Vis Sci. 2001;42:1024-1028.
16. Macha S, Mitra AK. Ocular disposition of ganciclovir and its monoester prodrugs following intravitreal administration using microdialysis. Drug Metab Dispos. 2002;30:670-675.
17. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:175-208.
18. Frambach DA, Valentine JL, Weiter JJ. Topical phenylephrine for mydriasis affects rabbit retinal pigment epithelial transport. Invest Ophthalmol Vis Sci. 1989;30:343-344.
19. Frambach DA, Valentine JL, Weiter JJ. Initial observations of rabbit retinal pigment epithelium-choroid-sclera preparations. Invest Ophthalmol Vis Sci. 1988;29:814-817.
20. Koyano S, Araie M, Eguchi S. Movement of fluorescein and its glucuronide across retinal pigment epithelium-choroid. Invest Ophthalmol Vis Sci. 1993;34:531-538.
21. Jensen RJ, Rizzo JF, 3rd, Ziv OR, Grumet A, Wyatt J. Thresholds for activation of rabbit retinal ganglion cells with an ultrafine, extracellular microelectrode. Invest Ophthalmol Vis Sci. 2003;44:3533-3543.
22. Neal M, Cunningham J, Lever I, Pezet S, Malcangio M. Mechanism by which brain-derived neurotrophic factor increases dopamine release from the rabbit retina. Invest Ophthalmol Vis Sci. 2003;44:791-798.
23. Baptiste DC, Hartwick AT, Jollimore CA, Baldridge WH, Chauhan BC, Tremblay F, Kelly ME. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina. Invest Ophthalmol Vis Sci. 2002;43:2666-2676.
24. Majumdar S, Macha S, Nashed Y, Mitra A. Expression of Peptide Transporters on the Rabbit Retina: A Strategy to Improve Retinal Delivery of Ganciclovir. Letters in Drug Design & Discovery. 2004;1:73-77.
25. Han YH, Sweet DH, Hu DN, Pritchard JB. Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. J Pharmacol Exp Ther. 2001;296:450-457.
26. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
27. Aukunuru JV, Sunkara G, Bandi N, Thoreson WB, Kompella UB. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor. Pharm Res. 2001;18:565-572.
28. Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB, Ganapathy V Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2001;42:47-54.
29. Bridges CC, El-Sherbeny A, Ola MS, Ganapathy V, Smith SB. Transcellular transfer of folate across the retinal pigment epithelium. Curr Eye Res. 2002;24:129-138.
30. Rajan PD, Kekuda R, Chancy CD, Huang W, Ganapathy V, Smith SB. Expression of the extraneuronal monoamine transporter in RPE and neural retina. Curr Eye Res. 2000;20:195-204.
31. Philp NJ, Wang D, Yoon H, Hjelmeland LM. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest Ophthalmol Vis Sci. 2003;44:1716-1721.
32. Majumdar S, Tirucherai GS, Pal D, Mitra AK. Functional differences in nucleoside and nucleobase transporters expressed on the rabbit corneal epithelial cell line (SIRC) and isolated rabbit cornea. AAPS Pharm Sci. 2003;5:E15.
33. Mahony WB, Domin BA, Zimmerman TP. Ganciclovir permeation of the human erythrocyte membrane. Biochem Pharmacol. 1991;41:263-271.
34. Henderson GI, Hu ZQ, Yang Y, Perez TB, Devi BG, Frosto TA, Schenker S. Ganciclovir transfer by human placenta and its effects on rat fetal cells. Am J Med Sci. 1993;306:151-156.
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
36. Mahony WB, Domin BA, McConnell RT, Zimmerman TP. Acyclovir transport into human erythrocytes. J Biol Chem. 1988;263:9285-9291.
37. Henderson GI, Hu ZQ, Johnson RF, Perez AB, Yang Y, Schenker S. Acyclovir transport by the human placenta. J Lab Clin Med. 1992;120:885-892.
38. Gutierrez MM, Giacomini KM. Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta. 1993;1149:202-208.
39. Balimane PV, Sinko PJ. Involvement of multiple transporters in the oral absorption of nucleoside analogues. Adv Drug Deliv Rev. 1999;39:183-209.
40. Meadows KC, Dressman JB. Mechanism of acyclovir uptake in rat jejunum. Pharm Res. 1990;7:299-303.
41. Majumdar S, Gunda S, Mitra A. Functional expression of a sodium dependent nucleoside transporter on rabbit cornea: Role in corneal permeation of acyclovir and idoxuridine. Curr Eye Res. 2003;26:175-183.
42. Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300:918-924.
43. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. JPharmacol Exp Ther. 2003;305:1087-1097.
44. Hosoya K, Horibe Y, Kim KJ, Lee VH. Nucleoside transport mechanisms in the pigmented rabbit conjunctiva. Invest Ophthalmol Vis Sci. 1998;39:372-377.
45. Griffith DA, Jarvis SM. Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta. 1996;1286:153-181.
46. Baldwin SA, Mackey JR, Cass CE, Young JD. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today. 1999;5:216-224.
47. Kiss A, Farah K, Kim J, Garriock RJ, Drysdale TA, Hammond JR. Molecular cloning and functional characterization of inhibitor-sensitive (mENTl) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain. Biochem J. 2000;352 Pt 2:363-372.
48. Kraupp M, Marz R. Nucleobase and nucleoside transport in mammalian cells. Wien Klin Wochenschr. 1995; 107:677-680.
49. Ward JL, Sherali A, Mo ZP, Tse CM. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem. 2000;275:8375-8381.
50. de Koning H, Diallinas G. Nucleobase transporters (review). Mol Membr Biol. 2000;17:75-94.